Characterization of echinocandin-resistant mutants of Candida albicans: Genetic, biochemical, and virulence studies

Infection and Immunity

Volumn 64, Issue 8, 1996, Pages 3244-3251

  Kurtz, M B ^a   Abruzzo, G ^a   Flattery, A ^a   Bartizal, K ^a   Marrinan, J A ^a   Li, W ^a   Milligan, J ^a   Nollstadt, K ^a   Douglas, C M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACULEACIN A; AMPHOTERICIN B; ECHINOCANDIN B; ECHINOCANDIN B DERIVATIVE; FLUCONAZOLE; GLUCAN SYNTHASE; ITRACONAZOLE; KETOCONAZOLE; L 687781; L 733560; NYSTATIN; PNEUMOCANDIN DERIVATIVE; TERBINAFINE; TUNICAMYCIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CROSS RESISTANCE; DRUG RESISTANCE; FEMALE; FUNGUS MUTANT; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030055323     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.8.3244-3251.1996     Document Type: Article

References (62)

1. Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, D. Krupa, V. B. Pikounis, H. Kropp, and K. Bartizal. 1995. Evaluation of water-soluble pneumocandins L-733,560, L-705,589, and L-731,373 in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 39:1077-1081.
2. Abruzzo, G. K., A. M. Flattery, C. J. Gill, J. G. Smith, H. Kropp, and K. F. Bartizal. 1993. Evaluation of water soluble lipopeptides L-733,560, L-705,589 and L-731,373 in a mouse model of disseminated aspergillosis, abstr. 355. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Angiolella, L., N. Simonetti, and A. Cassone. 1994. The lipopeptide antimycotic, cilofungin modulates the incorporation of glucan-associated proteins into the cell wall of Candida albicans. J. Antimicrob. Chemother. 33:1137-1146.
4. Bartizal, K., G. Abruzzo, C. Trainor, D. Krupa, K. Nollstadt, D. Schmatz, R. Schwartz, M. Hammond, J. Balkovec, and F. Vanmiddlesworth. 1992. In vitro antifungal activities and in vivo efficacies of 1,3-β-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydrocchinocandin B, and L-687,781, a papulacandin. Antimicrob. Agents Chemother. 36:1648-1657.
5. Beaulieu, D., J. Tang, D. J. Zeckner, and T. R. Parr. 1993. Correlation of cilofungin in vivo efficacy with its activity against Aspergillus fumigatus (1,3)-β-D-glucan synthase. FEMS Microbiol. Lett. 108:133-138.
6. Beckford, L. M., and D. Kerridge. 1991. The effect of echinocandin B and cilofungin on the activity of β-(1,3)-glucan synthetase in sensitive and resistant strains of Candida, abstr. PS3.11. In Proceedings of the XI Congress of the International Society for Human and Animal Mycology. Isham, Montreal, Canada.
7. Bernard, E. M., F. F. Edwards, D. Armstrong, and M. B. Kurtz. 1993. Activity of three pneumocandins in an animal model of pulmonary aspergillosis, abstr. 354. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. Boeke, M. D., F. LaCroute, and G. R. Fink. 1984. A positive selection for mutants lacking orotidine-5′-phosphate decarboxylase activity in yeast: 5-fluoroorotic acid resistance. Mol. Gen. Genet. 197:345-356.
9. 0 derivatives. J. Med. Chem. 37:222-225.
10. Cassone, A., R. E. Mason, and D. Kerridge. 1981. Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study. Sabouraudia 19:97-110.
11. Castro, C., J. C. Ribas, M. H. Valdivieso, R. Varona, F. Delrey, and A. Duran. 1995. Papulacandin B resistance in budding and fission yeasts: isolation and characterization of a gene involved in (1,3)β-D-glucan synthesis in Saccharomyces cerevisiae. J. Bacteriol. 177:5732-5739.
12. Conly, J., R. Rennie, J. Johnson, S. Farah, and L. Hellman. 1992. Disseminated candidiasis due to amphotericin B-resistant Candida albicans. J. Infect. Dis. 165:761-764.
13. De Bernardis, F., D. Adriani, R. Lorenzini, E. Pontieri, G. Carruba, and A. Cassone. 1993. Filamentous growth and elevated vaginopathogenic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection. Infect. Immun. 61:1500-1508.
14. Defever, K. S., W. L. Whelan, A. L. Rogers, E. S. Beneke, and J. M. Veselenak. 1982. Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates. Antimicrob. Agents Chemother. 22:810-815.
15. DeMora, J. F., R. Gil, R. Sentandreu, and E. Herrero. 1991. Isolation and characterization of Saccharomyces cerevisiae mutants resistant to aculeacin A. Antimicrob. Agents Chemother. 35:2596-2601.
16. Denning, D. W., and D. A. Stevens. 1991. Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis. Antimicrob. Agents Chemother. 35:1329-1333.
17. Douglas, C., J. Marrinan, K. Nollstadt, K. Bartizal, G. Abruzzo, A. Flattery, J. Curotto, J. Milligan, and M. Kurtz. 1994. Mode of action of pneumocandin analogs: genetic and virulence studies with Candida albicans, abstr. PO2.28 (D91). In Proceedings of the XII Congress of the International Society for Human and Animal Mycology. Isham, Adelaide, Australia.
18. Douglas, C. M., F. Foor, J. A. Marrinan, N. Morin, J. B. Nielsen, A. M. Dahl, P. Mazur, W. Baginasky, W. Li, M. El-Sherbeini, J. A. Clemas, S. M. Mandala, B. R. Frommer, and M. B. Kurtz. 1994. The Saccharomyces cerevisiae FKSI (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-β-D-glucan synthase. Proc. Natl. Acad. Sci. USA 91:12907-12911.
19. Douglas, C. M., J. A. Marrinan, W. Li, and M. B. Kurtz. 1994. A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-β-D-glucan synthase activity. J. Bacteriol. 176:5686-5696.
20. El-Sherbini, M., and J. A. Clemas. 1995. Concomitant nikkomycin Z super-sensitivity of an echinocandin-resistant mutant of Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 39:200-207.
21. Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene-mapping in Candida albicans. Genetics 134:717-728.
22. Gordee, R. S., D. J. Zeckner, L. F. Ellis, A. L. Thakkar, and L. C. Howard. 1984. In vitro and in vivo anti-Candida activity and toxicology of LY121019. J. Antibiotics. 37:1054-1065.
23. Goshhorn, A. K., and S. Scherer. 1989. Genetic analysis of prototrophic natural variants of Candida albicans. Genetics 123:667-673.
24. Gow, N., P. W. Robbins, J. W. Lester, A. Brown, W. A. Fonzi, T. Chapman, and O. S. Kinsman. 1994. A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans. Proc. Natl. Acad. Sci. USA 91:6216-6220.
25. Hilton, C., D. Markie, B. Corner, E. Rikkerink, and R. T. Poulter. 1985. Heat shock induces chromosome loss in the yeast Candida albicans. Mol. Gen. Genet. 200:162-168.
26. Hitchcock, C. A. 1993. Resistance of Candida albicans to azole antifungal agents. Biochem. Soc. Trans. 21:1039-1047.
27. Inoue, S. B., N. Takewaki, T. Takasuka, T. Mio, M. Adachi, Y. Fujii, C. Miyamoto, M. Arisawa, Y. Furuichi, and T. Watanabe. 1995. Characterization and gene cloning of 1,3-β-D-glucan synthase from Saccharomyces cerevisiae. Eur. J. Biochem. 231:845-854.
28. Inoue, S. B., N. Takewaki, T. Takasuka, T. Mio, M. Adachi, Y. Fujii, C. Miyamoto, M. Arisawa, Y. Furuichi, and T. Watanabe. 1995. Characterization and gene cloning of the 1,3-β-D-glucan synthase subunit from Saccharomyces cerevisiae. Yeast 11:S344.
29. Kirsch, D. R., and R. R. Whitney. 1991. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect. Immun. 59:3297-3300.
30. Knudsen, L. F., and J. M. Curtis. 1947. The use of the angular transformation in biological assays. J. Am. Stat. Assoc. 42:282-296.
31. Kurtz, M. B., G. K. Abruzzo, A. M. Flattery, J. A. Marrinan, W. Li, J. A. Milligan, K. Nollstadt, and C. M. Douglas. 1995. Isolation and characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical and virulence studies. Yeast 11:S561.
32. Kurtz, M. B., M. W. Cortelyou, and D. R. Kirsch. 1986. Integrative transformation of Candida albicans, using a cloned Candida albicans ADE2 gene. Mol. Cell. Biol. 6:142-149.
33. Kurtz, M. B., C. Douglas, J. Marrinan, K. Nollstadt, J. Onishi, S. Dreikorn, J. Milligan, S. Mandala, J. Thompson, J. M. Balkovec, F. A. Bouffard, J. F. Dropinski, M. L. Hammond, K. A. Zambias, G. Abruzzo, K. Bartizal, O. B. McManus, and M. L. Garcia. 1994. Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob. Agents Chemother. 38:2750-2757.
34. Kurtz, M. B., and S. Scherer. 1992. Molecular genetics of human fungal pathogens, p. 342-363. In J. W. Bennett and L. Lasure (ed.). More gene manipulations in fungi. Academic Press, San Diego.
35. Magee, B. B., Y. Koltin, J. A. Gorman, and P. T. Magee. 1988. Assignment of cloned genes to the seven electrophoretically separated Candida albicans chromosomes. Mol. Cell. Biol. 8:4721-4726.
36. Mazur, P., N. Morin, W. Baginsky, M. El-Sherbeini, J. A. Clemas, J. B. Nielsen, and F. Foor. 1995. Differential expression and function of two homologous subunits of yeast 1,3-β-D-glucan synthase. Mol. Cell. Biol. 15:5671-5681.
37. McIntyre, K. A., and J. N. Galgiani. 1989. pH and other effects on the antifungal activity of cilofungin (LY121019). Antimicrob. Agents Chemother. 33:731-735.
38. Mehta, R. J., J. M. Boyer, and C. H. Nash. 1984. Aculeacin resistant mutants of Candida albicans: alterations in cellular lipids. Microbios Lett. 27:25-29.
39. Mehta, R. J., C. H. Nash, S. F. Grappel, and P. Actor. 1982. Aculeacin A resistant mutants of Candida albicans. J. Antibiot. 35:707-711.
40. Mitchell, A., C. Douglas, J. d'Ippolito, G. J. Shei, and M. B. Kurtz. 1995. Homology of genes that confer echinocandin resistance in Saccharomyces cerevisiae and Candida albicans, abstr. 133. In abstracts of the 1995 Yeast Cell Biology Meeting. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
41. Mizuno, K., A. Yagi, S. Satoi, M. Takada, M. Hayashi, K. Asano, and T. Matsuda. 1977. Studies on aculeacin. I. Isolation and characterization of aculcacin A. J. Antibiot. 30:297-302.
42. Odds, F. C. 1993. Resistance of yeasts to azole-derivative antifungals. J. Antimicrob. Chemother. 31:463-471.
43. Onishi, J. Personal communication.
44. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
45. Ribas, J. C., C. Roncero, H. Rico, and Durán. 1991. Characterization of a Schizosaccharomyces pombe morphological mutant altered in the galactomannan content. FEMS Microbiol. Lett. 79:263-268.
46. Roder, B. L., C. Sonnenschein, and S. H. Hartzen. 1991. Failure of fluconazole therapy in Candida krusei fungemia. Eur. J. Clin. Microbiol. Infect. Dis. 10:173-173.
47. Sanguineti, A., J. K. Carmichael, and K. Campbell. 1993. Fluconazole-resistant Candida albicans after long-term suppressive therapy. Arch. Intern. Med. 153:1122-1124.
48. Sarachek, A., and L. A. Henderson. 1988. Variations for susceptibilities to ultraviolet induced cellular inactivation and gene segregation among protoplast fusion hybrids of Candida albicans. Cytobios 55:171-184.
49. Schmatz, D. M., M. A. Powles, D. C. McFadden, L. Pittarelli, J. Balkovec, M. Hammond, R. Zambias, P. Liberator, and J. Andersen. 1992. Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats. Antimicrob. Agents Chemother. 36:1964-1970.
50. Schmatz, D. M., M. A. Romancheck, L. A. Pittarelli, R. E. Schwartz, R. A. Fromtling, K. H. Nollstadt, F. L. Vanmiddlesworth, K. E. Wilson, and M. J. Turner. 1990. Treatment of Pneumocystis carinii pneumonia with 1,3-β-glucan synthesis inhibitors. Proc. Natl. Acad. Sci. USA 87:5950-5954.
51. Schwartz, R. E., D. F. Sesin, H. Joshua, K. E. Wilson, A. Kempf, K. E. Golken, D. Kuehner, P. Gaillot, C. Gleason, R. White, E. Inamine, G. Bills, P. Salmon, and L. Zitano. 1992. Pneumocandins from Zalerion arboricola. I. Discovery and isolation. J. Antibiot. 45:1853-1866.
52. Sherman, F., G. R. Fink, and C. W. Lawrence. 1983. Methods in yeast genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
53. Tam, J. Y., K. G. Blume, and C. G. Prober. 1992. Prophylactic fluconazole and Candida krusei infections. N. Engl. J. Med. 326:891.
54. Vanden Bossche, H., P. Marischal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-400.
55. Vanmiddlesworth, F., M. N. Omstead, D. Schmatz, K. Bartizal, R. Fromtling, and G. Bills. 1991. L-687,781, a new member of the papulacandin family of β-1,3-D-glucan synthesis inhibitors. I. Fermentation, isolation, and biological activity. J. Antibiot. 44:45-51.
56. Whelan, W. L. 1987. The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans. Crit. Rev. Microbiol. 15:45-56.
57. Whelan, W. L., and D. Kerridge. 1984. Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans. Antimicrob. Agents Chemother. 26:570-574.
58. Whelan, W. L., and P. T. Magee. 1981. Natural heterozygosity in Candida albicans. J. Bacteriol. 145:896-903.
59. Whelan, W. L., D. Markie, and K. J. Kwon-Chung. 1986. Complementation analysis of resistance to 5-fluorocytosine in Candida albicans. Antimicrob. Agents Chemother. 29:726-729.
60. Whelan, W. L., D. Markie, K. G. Simpkin, and R. M. Poulter. 1985. Instability of Candida albicans hybrids. J. Bacteriol. 161:1131-1136.
61. Wingard, J. R., W. G. Merz, M. G. Rinaldi, T. R. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New Engl. J. Med. 325:1274-1277.
62. Zeckner, D., T. Butler, C. Boylan, B. Boyll, Y. Lin, P. Raab, J. Sehmidtke, and W. Current. 1993. LY303366 activity against systemic aspergillosis and histoplasmosis in murine models, abstr. 364. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.